Dicronis
PrivateLast Round
Grant
May 7, 2019
Total Funding Raised
$460,400
Company Overview
Dicronis is a medical technology company that develops minimally invasive diagnostic devices for the assessment of lymphatic function, including its flagship Lymphit platform for the early detection of lymphedema.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dicronis Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Dicronis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 7, 2019 | ||||
| Accelerator | Jan 23, 2019 | ||||
| Grant | Oct 23, 2018 | ||||
| Grant | Dec 7, 2017 | ||||
| Grant | Dec 7, 2017 | ||||
Grant | Oct 1, 2017 |
Dicronis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Boldbrain Startup Challenge | Grant |
| Merck Accelerator | Accelerator |
| ETH Zurich Foundation | Grant |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2026
Monthly visitors grew 93% MoM.
- Jan 23, 2019
$57K raised from Merck Accelerator
Dicronis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dicronis's valuation, stock price, and market status.